418
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 240-252 | Received 15 Nov 2023, Accepted 29 Jan 2024, Published online: 13 Feb 2024

Figures & data

Table 1. Baseline characteristics.

Table 2. Healthcare utilization during the 6-month follow-up period.

Figure 1. Patient attrition. During the three influenza seasons observed between 2016–2019, 335,637 patients (209,571 treated and 126,066 untreated patients) met study inclusion criteria. The final matched cohort contained 116,901 matched patient pairs.

Figure 1. Patient attrition. During the three influenza seasons observed between 2016–2019, 335,637 patients (209,571 treated and 126,066 untreated patients) met study inclusion criteria. The final matched cohort contained 116,901 matched patient pairs.

Figure 2. Acute complications and mortality. Treated patients had lower rates of acute complications and mortality during the follow-up period (6 months after index date, defined as date of first claim with an influenza diagnosis).

Figure 2. Acute complications† and mortality. Treated patients had lower rates of acute complications and mortality during the follow-up period (6 months after index date, defined as date of first claim with an influenza diagnosis).

Figure 3. Healthcare costs (adjusted to 2019 US Dollars) during the 6-month follow-up period. Healthcare utilization and costs were generally statistically significantly lower in treated patients than in untreated patients.

Figure 3. Healthcare costs (adjusted to 2019 US Dollars) during the 6-month follow-up period. Healthcare utilization and costs were generally statistically significantly lower in treated patients than in untreated patients.

Appendix Table 1.

Availability of data and materials

The data that support the findings of this study originate from Medicare data, which are available from the Centers for Medicare and Medicaid through ResDAC (https://www.resdac.org/).